NOVARTIS AG (NVSEF)
Clinical trial NCT07203001 updates: 1. completion date: 2029-05-24 → 2028-05-17 2. primary completion date: 2029-05-24 → 2027-04-22 3. enrollment: 20 → 30 participants
Clinical trial NCT07203001 updates: 1. completion date: 2029-05-24 → 2028-05-17 2. primary completion date: 2029-05-24 → 2027-04-22 3. enrollment: 20 → 30 participants
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical